Online-Assisted Survey on Antibiotic Use by Pet Owners in Dogs and Cats
Abstract
:1. Introduction
2. Results
2.1. Pet Owner Demographics
2.2. Demographic Data of Dogs and Cats
2.3. Antibiotic Administration
2.3.1. Indications for Antibiotic Administration
2.3.2. Application Form
2.3.3. Duration and Frequency of Antibiotic Administration
2.3.4. Administered Antibiotics
2.3.5. Pet Owner Education by the Veterinarian and Pet Owner Compliance
2.3.6. Feasibility of Antibiotic Administration
2.3.7. Adverse Reactions and Premature Discontinuation of Administration
2.3.8. Culture and Sensitivity Testing before Antibiotic Administration
2.4. Preferred Route of Administration for Systemic Antibiotic Administration
2.5. Tablet Administration
2.6. Choosing an Antibiotic
3. Discussion
4. Material and Methods
Statistical Analysis
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- World Health Organization. Global Antimicrobial Resistance and Use Surveillance System (GLASS) Report: 2022; World Health Organization: Geneva, Switzerland, 2022. [Google Scholar]
- Collaborators, A.R. Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis. Lancet 2022, 399, 629–655. [Google Scholar]
- Cassini, A.; Högberg, L.D.; Plachouras, D.; Quattrocchi, A.; Hoxha, A.; Simonsen, G.S.; Colomb-Cotinat, M.; Kretzschmar, M.E.; Devleesschauwer, B.; Cecchini, M.; et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: A population-level modelling analysis. Lancet Infect. Dis. 2019, 19, 56–66. [Google Scholar] [CrossRef] [PubMed]
- World Health Organization. Overcoming antimicrobial resistance. In World Health Organization Report on Infectious Diseases 2000; World Health Organization: Geneva, Switzerland, 2000. [Google Scholar]
- Guardabassi, L.; Apley, M.; Olsen, J.E.; Toutain, P.L.; Weese, S. Optimization of Antimicrobial Treatment to Minimize Resistance Selection. Microbiol. Spectr. 2018, 6, 637–673. [Google Scholar] [CrossRef] [PubMed]
- Marco-Fuertes, A.; Marin, C.; Lorenzo-Rebenaque, L.; Vega, S.; Montoro-Dasi, L. Antimicrobial Resistance in Companion Animals: A New Challenge for the One Health Approach in the European Union. Vet. Sci. 2022, 9, 208. [Google Scholar] [CrossRef] [PubMed]
- Joosten, P.; Ceccarelli, D.; Odent, E.; Sarrazin, S.; Graveland, H.; Van Gompel, L.; Battisti, A.; Caprioli, A.; Franco, A.; Wagenaar, J.A.; et al. Antimicrobial Usage and Resistance in Companion Animals: A Cross-Sectional Study in Three European Countries. Antibiotics 2020, 9, 87. [Google Scholar] [CrossRef] [PubMed]
- Pomba, C.; Rantala, M.; Greko, C.; Baptiste, K.E.; Catry, B.; van Duijkeren, E.; Mateus, A.; Moreno, M.A.; Pyörälä, S.; Ružauskas, M.; et al. Public health risk of antimicrobial resistance transfer from companion animals. J. Antimicrob. Chemother. 2017, 72, 957–968. [Google Scholar] [CrossRef] [PubMed]
- Bhat, A.H. Bacterial zoonoses transmitted by household pets and as reservoirs of antimicrobial resistant bacteria. Microb. Pathog. 2021, 155, 104891. [Google Scholar] [CrossRef]
- Zentralverband Zoologischer Fachbetriebe Deutschlands e.V. (ZZF), Industrieverband Heimtierbedarf (IVH) e.V. Der deutsche Heimtiermarkt 2023 Struktur & Umsatzdaten. Available online: https://www.ivh-online.de/der-verband/daten-fakten/der-deutsche-heimtiermarkt.html (accessed on 23 March 2024).
- Bundestierärztekammer, Federal Veterinary Surgeons’ Association. Guidelines for the Prudent Use of Veterinary Antimicrobial Drugs; Addendum to the German Veterinary Gazette 3/2015; Schlütersche Fachmedien GmbH: Hanover, Germany, 2015. [Google Scholar]
- Bundestierärztekammer. Die neue TÄHAV ist in Kraft; Deutsches Tierärzteblatt, Bundestierärztekammer e.V.: Berlin, Germany, 2018; pp. 484–489. [Google Scholar]
- World Health Organization. Critically Important Antimicrobials for Human Medicine, 6th ed.; World Health Organization: Geneva, Switzerland, 2019. [Google Scholar]
- World Organisation for Animal Health. OIE List of Antimicrobial Agents of Veterinary Importance; OIE-World Organisation for Animal Health: Paris, France, 2021. [Google Scholar]
- Bundesamt für Verbraucherschutz und Lebensmittelsicherheit (BVL). Deutlich Geringere Abgabemengen von Antibiotika in der Tiermedizin. 2022. Available online: https://www.bvl.bund.de/SharedDocs/Pressemitteilungen/05_tierarzneimittel/2022/2022_PM_Abgabemengen_Antibiotika_Tiermedizin.html (accessed on 1 February 2024).
- Bundesamt für Verbraucherschutz und Lebensmittelsicherheit. Abgabemengen von Antibiotika in Tiermedizin Gehen Weiter Zurück; Weiterer Rückgang auch bei Fluorchinolonen, Cephalosporinen der 3. und 4. Generation Sowie bei Polypeptidantibiotika. 2023. Available online: https://www.bvl.bund.de/SharedDocs/Pressemitteilungen/05_tierarzneimittel/2023/2023_PM_Abgabemengen_Antibiotika_Tiermedizin.html (accessed on 1 February 2024).
- Mohr, K.; Nolff, M.; Zablotski, Y.; Dittus, T.; Korbel, R.; Meyer-Lindenberg, A.; Wolf, G.; Hiss, K.; Peters, H.; Schulz, B. Influence of the Verordnung über Tierärztliche Hausapotheken on antimicrobial use in dogs and cats in Bavaria. Tieraerztliche Prax. Ausg. K Kleintiere/Heimtiere 2022, 50, 337–347. [Google Scholar]
- Moerer, M.; Merle, R.; Bäumer, W. A Cross-Sectional Study of Veterinarians in Germany on the Impact of the TÄ HAV Amendment 2018 on Antimicrobial Use and Development of Antimicrobial Resistance in Dogs and Cats. Antibiotics 2022, 11, 484. [Google Scholar]
- Moerer, M.; Merle, R.; Bäumer, W. Antibiotikaeinsatz und Resistenzentwicklung bei Hund und Katze unter dem Einfluss der TÄHAV-Novelle 2018—Ein Stimmungsbild Berliner Tierärzte. Berl. Und Münchener Tierärztliche Wochenschr. 2022, 135, 1–13. [Google Scholar]
- Smith, M.; King, C.; Davis, M.; Dickson, A.; Park, J.; Smith, F.; Currie, K.; Flowers, P. Pet owner and vet interactions: Exploring the drivers of AMR. Antimicrob. Resist. Infect. Control 2018, 7, 46. [Google Scholar] [CrossRef]
- Redding, L.E.; Cole, S.D. Pet owners’ knowledge of and attitudes toward the judicious use of antimicrobials for companion animals. J. Am. Vet. Med. Assoc. 2019, 254, 626–635. [Google Scholar] [CrossRef] [PubMed]
- De Briyne, N.; Atkinson, J.; Pokludova, L.; Borriello, S.; Price, S. Factors influencing antibiotic prescribing habits and use of sensitivity testing amongst veterinarians in Europe. Vet. Rec. 2013, 173, 475. [Google Scholar] [CrossRef] [PubMed]
- Burke, S.; Black, V.; Sánchez-Vizcaíno, F.; Radford, A.; Hibbert, A.; Tasker, S. Use of cefovecin in a UK population of cats attending first-opinion practices as recorded in electronic health records. J. Feline Med. Surg. 2016, 19, 687–692. [Google Scholar] [CrossRef]
- Stein, M.R.; Weese, J.S.; Stull, J.W.; McClure, J.T.; Evason, M. Knowledge, attitudes and influencers of cat owners in North America around antimicrobials and antimicrobial stewardship. J. Feline Med. Surg. 2022, 24, e90–e97. [Google Scholar] [CrossRef]
- Stein, M.R.; Evason, M.D.; Stull, J.W.; McClure, J.T.; Weese, J.S. Knowledge, attitudes and influencers of North American dog-owners surrounding antimicrobials and antimicrobial stewardship. J. Small Anim. Pr. 2021, 62, 442–449. [Google Scholar] [CrossRef]
- Stallwood, J.; Shirlow, A.; Hibbert, A. A UK-based survey of cat owners’ perceptions and experiences of antibiotic usage. J. Feline Med. Surg. 2020, 22, 69–76. [Google Scholar] [CrossRef]
- Akoglu, H. User’s guide to correlation coefficients. Turk. J. Emerg. Med. 2018, 18, 91–93. [Google Scholar] [CrossRef] [PubMed]
- Candellone, A.; Badino, P.; Girolami, F.; Ala, U.; Mina, F.; Odore, R. Dog Owners’ Attitude toward Veterinary Antibiotic Use and Antibiotic Resistance with a Focus on Canine Diarrhea Management. Animals 2023, 13, 1061. [Google Scholar] [CrossRef]
- Robbins, S.N.; Goggs, R.; Lhermie, G.; Lalonde-Paul, D.F.; Menard, J. Antimicrobial Prescribing Practices in Small Animal Emergency and Critical Care. Front. Vet. Sci. 2020, 7, 110. [Google Scholar] [CrossRef]
- Werner, M.; Unterer, S. Use of antimicrobials in acute canine diarrhea—Overview of potential risks, indications and alternatives. Tieraerztliche Prax. Ausg. K Kleintiere/Heimtiere 2021, 49, 110–120. [Google Scholar]
- Werner, M.; Suchodolski, J.S.; Straubinger, R.K.; Wolf, G.; Steiner, J.M.; Lidbury, J.A.; Neuerer, F.; Hartmann, K.; Unterer, S. Effect of amoxicillin-clavulanic acid on clinical scores, intestinal microbiome, and amoxicillin-resistant Escherichia coli in dogs with uncomplicated acute diarrhea. J. Vet. Intern. Med. 2020, 34, 1166–1176. [Google Scholar] [CrossRef] [PubMed]
- Beckmann, K.; Favrot, C.; Fischer, N.; Francey, T.; Gerber, B.; Glaus, T.; Grundmann, S.; Hettlich, B.; Hofmann-Lehmann, R.; Knell, S.; et al. Strategie Antibiotikaresistenzen. Umsichtiger Einsatz von Antibiotika bei Hunden und Katzen. Therapieleitfaden Für Tierärztinnen Und Tierärzte. 2019. Available online: https://www.blv.admin.ch/dam/blv/de/dokumente/tiere/tierkrankheiten-und-arzneimittel/tierarzneimittel/therapieleitfaden-antibiotika-hunde-katzen.pdf.download.pdf/Leitfaden_Kleintier_final_publ_d.pdf (accessed on 23 March 2024). [CrossRef]
- Brissot, H.; Cervantes, S.; Guardabassi, L.; Hibbert, A.; Lefebvre, H.; Mateus, A.L.P.; Noli, C.; Nuttall, T.; Pomba, C.; Schulz, B. GRAM: Guidance for the Rational Use of Antimicrobials: Recommendations for Dogs and Cats, 2nd ed.; Ceva Santé Animale: Libourne, France, 2016. [Google Scholar]
- Federation of European Companion Animal Veterinary Associations (FECAVA). FECAVA Advice on Responsible Use of Antimicrobials. 2018. Available online: https://www.fecava.org/wp-content/uploads/2020/01/FECAVA-Advice-on-Responsible-use-of-Antimicrobials-ENGLISH.pdf (accessed on 6 September 2023).
- Federation of European Companion Animal Veterinary Associations (FECAVA). FECAVA Recommendations for Appropriate Antimicrobial Therapy. 2018. Available online: https://www.fecava.org/wp-content/uploads/2020/01/FECAVA-Recommendations-for-Appropriate-Antimicrobial-ENGLISH-1.pdf (accessed on 1 February 2024).
- Jessen, L.; Damborg, P.; Spohr, A.; Goericke-Pesch, S.; Langhorn, R.; Houser, G.; Willesen, J.; Schjaerff, M.; Søerensen, T.; Eriksen, T.; et al. Antibiotic Use Guidelines for Companion Animal Practice, 2nd ed.; Companion Animal Group, Danish Veterinary Association: Frederiksberg, Denmark, 2018. [Google Scholar]
- Shmalberg, J.; Montalbano, C.; Morelli, G.; Buckley, G.J. A Randomized Double Blinded Placebo-Controlled Clinical Trial of a Probiotic or Metronidazole for Acute Canine Diarrhea. Front. Vet. Sci. 2019, 6, 163. [Google Scholar] [CrossRef] [PubMed]
- Hall, M. Antimicrobial treatment of simple cutaneous abscesses. J. Am. Vet. Med. Assoc. 2010, 236, 620. [Google Scholar] [PubMed]
- Frey, E.; Costin, M.; Granick, J.; Kornya, M.; Weese, J.S. 2022 AAFP/AAHA Antimicrobial Stewardship Guidelines. J. Am. Anim. Hosp. Assoc. 2022, 58, 1–5. [Google Scholar] [CrossRef] [PubMed]
- Davis, E.M. The Use of Antibiotics in Veterinary Dentistry. Today’s Vet. Pract. 2023, 87–107. Available online: https://todaysveterinarypractice.com/dentistry/antibiotics-in-veterinary-dentistry/ (accessed on 23 March 2024).
- Lappin, M.R.; Blondeau, J.; Boothe, D.; Breitschwerdt, E.B.; Guardabassi, L.; Lloyd, D.H.; Papich, M.G.; Rankin, S.C.; Sykes, J.E.; Turnidge, J.; et al. Antimicrobial use Guidelines for Treatment of Respiratory Tract Disease in Dogs and Cats: Antimicrobial Guidelines Working Group of the International Society for Companion Animal Infectious Diseases. J. Vet. Intern. Med. 2017, 31, 279–294. [Google Scholar] [CrossRef] [PubMed]
- Harrer, J.; Dorsch, R. Bacterial urinary tract infection and subclinical bacteriuria in the dog: A current review. Tieraerztliche Prax. Ausg. K Kleintiere/Heimtiere 2020, 48, 270–284. [Google Scholar]
- Dorsch, R.; Teichmann-Knorrn, S.; Lund, H.S. Urinary tract infection and subclinical bacteriuria in cats: A clinical update. J. Feline Med. Surg. 2019, 21, 1023–1038. [Google Scholar] [CrossRef]
- Gerber, B.; Boretti, F.S.; Kley, S.; Laluha, P.; Müller, C.; Sieber, N.; Unterer, S.; Wenger, M.; Flückiger, M.; Glaus, T.; et al. Evaluation of clinical signs and causes of lower urinary tract disease in European cats. J. Small Anim. Pract. 2005, 46, 571–577. [Google Scholar] [CrossRef]
- Dorsch, R.; Remer, C.; Sauter-Louis, C.; Hartmann, K. Feline lower urinary tract disease in a German cat population. A retrospective analysis of demographic data, causes and clinical signs. Tieraerztliche Prax. Ausg. K Kleintiere/Heimtiere 2014, 42, 231–239. [Google Scholar]
- Weese, J.S.; Blondeau, J.; Boothe, D.; Guardabassi, L.G.; Gumley, N.; Papich, M.; Jessen, L.R.; Lappin, M.; Rankin, S.; Westropp, J.L.; et al. International Society for Companion Animal Infectious Diseases (ISCAID) guidelines for the diagnosis and management of bacterial urinary tract infections in dogs and cats. Vet. J. 2019, 247, 8–25. [Google Scholar] [CrossRef] [PubMed]
- Schnepf, A.; Kramer, S.; Wagels, R.; Volk, H.A.; Kreienbrock, L. Evaluation of Antimicrobial Usage in Dogs and Cats at a Veterinary Teaching Hospital in Germany in 2017 and 2018. Front. Vet. Sci. 2021, 8, 689018. [Google Scholar] [CrossRef] [PubMed]
- Hur, B.A.; Hardefeldt, L.Y.; Verspoor, K.M.; Baldwin, T.; Gilkerson, J.R. Describing the antimicrobial usage patterns of companion animal veterinary practices; free text analysis of more than 4.4 million consultation records. PLoS ONE 2020, 15, e0230049. [Google Scholar] [CrossRef] [PubMed]
- Buckland, E.L.; O’Neill, D.; Summers, J.; Mateus, A.; Church, D.; Redmond, L.; Brodbelt, D. Characterisation of antimicrobial usage in cats and dogs attending UK primary care companion animal veterinary practices. Vet. Rec. 2016, 179, 489. [Google Scholar] [CrossRef] [PubMed]
- Löscher, W.; Richter, A. Lehrbuch der Pharmakologie und Toxikologie für die Veterinärmedizin; Enke Verlag: Stuttgart, Germany, 2016. [Google Scholar]
- Giguère, S.; Prescott, J.F.; Dowling, P.M. Antimicrobial Therapy in Veterinary Medicine; Wiley: Hoboken, NJ, USA, 2013. [Google Scholar]
- Chaitman, J.; Ziese, A.L.; Pilla, R.; Minamoto, Y.; Blake, A.B.; Guard, B.C.; Isaiah, A.; Lidbury, J.A.; Steiner, J.M.; Unterer, S.; et al. Fecal Microbial and Metabolic Profiles in Dogs With Acute Diarrhea Receiving Either Fecal Microbiota Transplantation or Oral Metronidazole. Front. Vet. Sci. 2020, 7, 192. [Google Scholar] [CrossRef] [PubMed]
- Manchester, A.C.; Dow, S.; Chow, L.; Gagne, J.; Lappin, M.R. Efficacy of an elemental diet in achieving clinical remission in dogs with chronic enteropathy. J. Vet. Intern. Med. 2023, 37, 2322–2333. [Google Scholar] [CrossRef] [PubMed]
- Volkmann, M.; Steiner, J.M.; Fosgate, G.T.; Zentek, J.; Hartmann, S.; Kohn, B. Chronic Diarrhea in Dogs—Retrospective Study in 136 Cases. J. Vet. Intern. Med. 2017, 31, 1043–1055. [Google Scholar] [CrossRef] [PubMed]
- Fujishiro, M.A.; Lidbury, J.A.; Pilla, R.; Steiner, J.M.; Lappin, M.R.; Suchodolski, J.S. Evaluation of the effects of anthelmintic administration on the fecal microbiome of healthy dogs with and without subclinical Giardia spp. and Cryptosporidium canis infections. PLoS ONE 2020, 15, e0228145. [Google Scholar] [CrossRef]
- Lee, N.N.; Bidot, W.A.; Ericsson, A.C.; Franklin, C.L. Effects of Giardia lamblia Colonization and Fenbendazole Treatment on Canine Fecal Microbiota. J. Am. Assoc. Lab. Anim. Sci. 2020, 59, 423–429. [Google Scholar] [CrossRef]
- Ciuca, L.; Pepe, P.; Bosco, A.; Caccio, S.M.; Maurelli, M.P.; Sannella, A.R.; Vismarra, A.; Cringoli, G.; Kramer, L.; Rinaldi, L.; et al. Effectiveness of Fenbendazole and Metronidazole Against Giardia Infection in Dogs Monitored for 50-Days in Home-Conditions. Front. Vet. Sci. 2021, 8, 626424. [Google Scholar] [CrossRef]
- Hardefeldt, L.; Hur, B.; Verspoor, K.; Baldwin, T.; Bailey, K.E.; Scarborough, R.; Richards, S.; Billman-Jacobe, H.; Browning, G.F.; Gilkerson, J. Use of cefovecin in dogs and cats attending first-opinion veterinary practices in Australia. Vet. Rec. 2020, 187, e95. [Google Scholar] [CrossRef]
- Murphy, C.P.; Reid-Smith, R.J.; Boerlin, P.; Weese, J.S.; Prescott, J.F.; Janecko, N.; McEwen, S.A. Out-patient antimicrobial drug use in dogs and cats for new disease events from community companion animal practices in Ontario. Can. Vet. J. 2012, 53, 291–298. [Google Scholar]
- Taylor, S.; Caney, S.; Bessant, C.; Gunn-Moore, D. Online survey of owners’ experiences of medicating their cats at home. J. Feline Med. Surg. 2022, 24, 1283–1293. [Google Scholar] [CrossRef] [PubMed]
- Adenot, C.C.; Abdelhakim, H.E. Palatability assessment of oral dosage forms for companion animals: A systematic review. J. Drug Deliv. Sci. Technol. 2022, 77, 103841. [Google Scholar] [CrossRef]
- Maddison, J.; Cannon, M.; Davies, R.; Farquhar, R.; Faulkner, B.; Furtado, T.; Harvey, G.; Leathers, F.; Snowden, A.; Wright, I. Owner compliance in veterinary practice: Recommendations from a roundtable discussion. Companion Anim. 2021, 26, S1–S12. [Google Scholar] [CrossRef]
- Grave, K.; Tanem, H. Compliance with short-term oral antibacterial drug treatment in dogs. J. Small Anim. Pract. 1999, 40, 158–162. [Google Scholar] [CrossRef]
- Adams, V.; Campbell, J.; Waldner, C.; Dowling, P.; Shmon, C. Evaluation of client compliance with short-term administration of antimicrobials to dogs. J. Am. Vet. Med. Assoc. 2005, 226, 567–574. [Google Scholar] [CrossRef]
- Barter, L.S.; Watson, A.D.; Maddison, J.E. Owner compliance with short term antimicrobial medication in dogs. Aust. Vet. J. 1996, 74, 277–280. [Google Scholar] [CrossRef]
- Paes, A.H.P.; Bakker, A.; Soe-Agnie, C.J. Impact of Dosage Frequency on Patient Compliance. Diabetes Care 1997, 20, 1512–1517. [Google Scholar] [CrossRef]
- Claxton, A.J.; Cramer, J.; Pierce, C. A systematic review of the associations between dose regimens and medication compliance. Clin. Ther. 2001, 23, 1296–1310. [Google Scholar] [CrossRef] [PubMed]
- Eisen, S.A.; Miller, D.K.; Woodward, R.S.; Spitznagel, E.; Przybeck, T.R. The effect of prescribed daily dose frequency on patient medication compliance. Arch Intern. Med. 1990, 150, 1881–1884. [Google Scholar] [CrossRef] [PubMed]
- Scarborough, R.; Hardefeldt, L.; Browning, G.; Bailey, K. Pet Owners and Antibiotics: Knowledge, Opinions, Expectations, and Communication Preferences. Antibiotics 2021, 10, 1326. [Google Scholar] [CrossRef] [PubMed]
Overall n = 708 | Dogs n = 463 | Cats n = 245 | p-Value 1 | q-Value 2 | Cramer’s V 3 | 95% CI 4 | |
---|---|---|---|---|---|---|---|
Wound infection/abscess/bite injury | 131 (18.5%) | 74 (16.0%) | 57 (23.3%) | 0.018 | 0.047 | 0.08 | 0.00–1.00 |
Diarrhea | 107 (15.1%) | 85 (18.4%) | 22 (9.0%) | <0.001 | 0.003 | 0.12 | 0.05–1.00 |
Dental treatment | 90 (12.7%) | 38 (8.2%) | 52 (21.2%) | <0.001 | <0.001 | 0.18 | 0.12–1.00 |
Urinary tract infection | 74 (10.5%) | 49 (10.6%) | 25 (10.2%) | 0.875 | 0.875 | 0.00 | 0.00–1.00 |
Surgery on soft tissue | 69 (9.7%) | 52 (11.2%) | 17 (6.9%) | 0.067 | 0.107 | 0.06 | 0.00–1.00 |
Infection of the upper respiratory tract | 63 (8.9%) | 22 (4.8%) | 41 (16.7%) | <0.001 | <0.001 | 0.20 | 0.13–1.00 |
Vomiting | 59 (8.3%) | 45 (9.7%) | 14 (5.7%) | 0.067 | 0.107 | 0.06 | 0.00–1.00 |
Infection of the lower respiratory tract | 54 (7.6%) | 30 (6.5%) | 24 (9.8%) | 0.114 | 0.165 | 0.05 | 0.00–1.00 |
Skin problems | 50 (7.1%) | 37 (8.0%) | 13 (5.3%) | 0.185 | 0.246 | 0.03 | 0.00–1.00 |
Ear infection | 50 (7.1%) | 40 (8.6%) | 10 (4.1%) | 0.024 | 0.056 | 0.08 | 0.00–1.00 |
Fever | 47 (6.6%) | 27 (5.8%) | 20 (8.2%) | 0.236 | 0.290 | 0.02 | 0.00–1.00 |
Castration/neutering | 42 (5.9%) | 34 (7.3%) | 8 (3.3%) | 0.029 | 0.058 | 0.07 | 0.00–1.00 |
Eye problem | 34 (4.8%) | 21 (4.5%) | 13 (5.3%) | 0.648 | 0.741 | 0.00 | 0.00–1.00 |
Surgery of the bones | 28 (4.0%) | 27 (5.8%) | 1 (0.4%) | <0.001 | 0.002 | 0.13 | 0.06–1.00 |
Other surgery | 12 (1.7%) | 7 (1.5%) | 5 (2.0%) | 0.761 | 0.811 | 0.00 | 0.00–1.00 |
Other problem | 97 (13.7%) | 82 (17.7%) | 15 (6.1%) | <0.001 | <0.001 | 0.16 | 0.09–1.00 |
Type of Administration and Formulation | Overall n = 708 | Dogs n = 463 | Cats n = 245 | p-Value 1 | q-Value 2 | Cramer’s V 3 | 95% CI 4 |
---|---|---|---|---|---|---|---|
Tablets | 581 (82.1%) | 402 (86.8%) | 179 (73.1%) | <0.001 | <0.001 | 0.17 | 0.10–1.00 |
Injections | 182 (25.7%) | 113 (24.4%) | 69 (28.2%) | 0.276 | 0.349 | 0.02 | 0.00–1.00 |
Type of injection | <0.001 | <0.001 | 0.36 | 0.23–1.00 | |||
Short-acting | 128/158 (81.0%) | 89/96 (92.7%) | 39/62 (62.9%) | ||||
Long-acting | 30/158 (19.0%) | 7/96 (7.3%) | 23/62 (37.1%) | ||||
Topical | 44 (6.2%) | 32 (6.9%) | 12 (4.9%) | 0.291 | 0.349 | 0.01 | 0.00–1.00 |
Oral solution/suspension/paste | 38 (5.4%) | 8 (1.7%) | 30 (12.2%) | <0.001 | <0.001 | 0.22 | 0.16–1.00 |
Capsules | 8 (1.1%) | 5 (1.1%) | 3 (1.2%) | >0.999 | >0.999 | 0.00 | 0.00–1.00 |
Overall n = 708 | Dogs n = 463 | Cats n = 245 | p-Value 1 | q-Value 2 | Cramer’s V 3 | 95% CI 4 | |
---|---|---|---|---|---|---|---|
Penicillins (aminopenicillins): | |||||||
Amoxicillin | 101 (14.8%) | 66 (15.0%) | 35 (14.6%) | 0.893 | >0.999 | 0.00 | 0.00–1.00 |
Ampicillin | 2 (0.3%) | 0 (0.0%) | 2 (0.8%) | 0.124 | 0.357 | 0.06 | 0.00–1.00 |
Penicillin | 2 (0.3%) | 2 (0.5%) | 0 (0.0%) | 0.543 | 0.769 | 0.01 | 0.00–1.00 |
Penicillins (aminopenicillins with beta-lactamase inhibitors): | |||||||
Amoxicillin/Clavulanic acid | 221 (32.5%) | 145 (32.9%) | 76 (31.7%) | 0.747 | 0.907 | 0.00 | 0.00–1.00 |
Nitroimidazoles: | |||||||
Metronidazole | 47 (6.9%) | 35 (7.9%) | 12 (5.0%) | 0.149 | 0.361 | 0.04 | 0.00–1.00 |
Tetracyclines: | |||||||
Doxycycline | 46 (6.8%) | 25 (5.7%) | 21 (8.8%) | 0.126 | 0.357 | 0.04 | 0.00–1.00 |
Lincosamides: | |||||||
Clindamycin | 18 (2.6%) | 9 (2.0%) | 9 (3.8%) | 0.184 | 0.391 | 0.03 | 0.00–1.00 |
Fluorochinolones: | |||||||
Enrofloxacin | 18 (2.6%) | 13 (2.9%) | 5 (2.1%) | 0.502 | 0.769 | 0.00 | 0.00–1.00 |
Marbofloxacin | 15 (2.2%) | 9 (2.0%) | 6 (2.5%) | 0.697 | 0.907 | 0.00 | 0.00–1.00 |
Pradofloxacin | 2 (0.3%) | 1 (0.2%) | 1 (0.4%) | >0.999 | >0.999 | 0.00 | 0.00–1.00 |
Cephalosporins: | |||||||
Cefovecin (3rd generation) | 13 (1.9%) | 1 (0.2%) | 12 (5.0%) | <0.001 | <0.001 | 0.16 | 0.10–1.00 |
Cefalexin (1st generation) | 12 (1.8%) | 12 (2.7%) | 0 (0.0%) | 0.011 | 0.091 | 0.09 | 0.00–1.00 |
Cefazolin (1st generation) | 1 (0.1%) | 0 (0.0%) | 1 (0.4%) | 0.352 | 0.599 | 0.04 | 0.00–1.00 |
Trimethoprim and Sulfonamides (TSO) | 6 (0.9%) | 6 (1.4%) | 0 (0.0%) | 0.095 | 0.357 | 0.06 | 0.00–1.00 |
Aminoglycosides: | |||||||
Gentamicin | 1 (0.1%) | 1 (0.2%) | 0 (0.0%) | >0.999 | >0.999 | 0.00 | 0.00–1.00 |
Other | 7 (1.0%) | 3 (0.7%) | 4 (1.7%) | 0.250 | 0.472 | 0.03 | 0.00–1.00 |
Unknown | 242 (35.5%) | 167 (37.9%) | 75 (31.2%) | 0.085 | 0.357 | 0.05 | 0.00–1.00 |
n = 44 | n = 44 | ||
---|---|---|---|
Polymyxin | 9 (20.5%) | Fusidic acid | 1 (2.3%) |
Gentamicin | 7 (15.9%) | Moxifloxacin | 1 (2.3%) |
Chloramphenicol | 6 (13.6%) | Oxytetracycline | 1 (2.3%) |
Ofloxacin | 5 (11.4%) | Neomycin | 1 (2.3%) |
Chlortetracycline | 2 (4.5%) | Polymyxin/neomycin sulfate/gramicidin | 0 (0.0%) |
Marbofloxacin | 2 (4.5%) | Other antibiotic | 4 (9.1%) |
Florfenicol | 1 (2.3%) | Unknown | 10 (22.7%) |
Overall n = 613 | Dogs n = 409 | Cats n = 204 | p-Value 1 | q-Value 2 | Cramer’s V 3 | 95% CI 4 | |
How well were you able to give your animal the antibiotic? | <0.001 | <0.001 | 0.26 | 0.18–1.00 | |||
Not at all | 4 (0.7%) | 0 (0.0%) | 4 (2.0%) | ||||
Rather less good | 23 (3.8%) | 9 (2.2%) | 14 (6.9%) | ||||
Neutral | 77 (12.6%) | 34 (8.3%) | 43 (21.1%) | ||||
Rather good | 99 (16.2%) | 61 (14.9%) | 38 (18.6%) | ||||
Very good | 410 (66.9%) | 305 (74.6%) | 105 (51.5%) | ||||
Overall n = 44 | Dogs n = 32 | Cats n = 12 | p-Value 1 | q-Value 2 | Cramer’s V 3 | 95% CI 4 | |
How well were you able to apply the antibiotic topically to your animal? | 0.089 | 0.089 | 0.29 | 0.00–1.00 | |||
Not at all | 1 (2.3%) | 1 (3.1%) | 0 (0.0%) | ||||
Rather less good | 4 (9.1%) | 1 (3.1%) | 3 (25.0%) | ||||
Neutral | 8 (18.2%) | 6 (18.8%) | 2 (16.7%) | ||||
Rather good | 10 (22.7%) | 6 (18.8%) | 4 (33.3%) | ||||
Very good | 21 (47.7%) | 18 (56.2%) | 3 (25.0%) |
Overall n = 584 | Dogs n = 404 | Cats n = 180 | p-Value 1 | q-Value 2 | Cramer’s V 3 | 95% CI 4 | |
---|---|---|---|---|---|---|---|
Hidden in food/treats | 264 (45.2%) | 192 (47.5%) | 72 (40.0%) | 0.092 | 0.105 | 0.06 | 0.00–1.00 |
With food | 201 (34.4%) | 165 (40.8%) | 36 (20.0%) | <0.001 | <0.001 | 0.20 | 0.13–1.00 |
Given directly into the mouth | 151 (25.9%) | 86 (21.3%) | 65 (36.1%) | <0.001 | <0.001 | 0.15 | 0.08–1.00 |
Eating the tablets/capsules out of the hand without any additional aids | 90 (15.4%) | 69 (17.1%) | 21 (11.7%) | 0.094 | 0.105 | 0.06 | 0.00–1.00 |
Crushed tablets to powder and mixed with food/treats | 39 (6.7%) | 14 (3.5%) | 25 (13.9%) | <0.001 | <0.001 | 0.19 | 0.12–1.00 |
With tablet dispenser | 18 (3.1%) | 1 (0.2%) | 17 (9.4%) | <0.001 | <0.001 | 0.24 | 0.17–1.00 |
Crushed tablets to powder and injected into mouth with liquid via syringe | 18 (3.1%) | 4 (1.0%) | 14 (7.8%) | <0.001 | <0.001 | 0.18 | 0.11–1.00 |
With special treat, trojaner | 17 (2.9%) | 3 (0.7%) | 14 (7.8%) | <0.001 | <0.001 | 0.19 | 0.12–1.00 |
Capsule content given without capsule | 2 (0.3%) | 0 (0.0%) | 2 (1.1%) | 0.095 | 0.105 | 0.08 | 0.00–1.00 |
Other | 12 (2.1%) | 7 (1.7%) | 5 (2.8%) | 0.528 | 0.528 | 0.00 | 0.00–1.00 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Rocholl, C.; Zablotski, Y.; Schulz, B. Online-Assisted Survey on Antibiotic Use by Pet Owners in Dogs and Cats. Antibiotics 2024, 13, 382. https://doi.org/10.3390/antibiotics13050382
Rocholl C, Zablotski Y, Schulz B. Online-Assisted Survey on Antibiotic Use by Pet Owners in Dogs and Cats. Antibiotics. 2024; 13(5):382. https://doi.org/10.3390/antibiotics13050382
Chicago/Turabian StyleRocholl, Clara, Yury Zablotski, and Bianka Schulz. 2024. "Online-Assisted Survey on Antibiotic Use by Pet Owners in Dogs and Cats" Antibiotics 13, no. 5: 382. https://doi.org/10.3390/antibiotics13050382
APA StyleRocholl, C., Zablotski, Y., & Schulz, B. (2024). Online-Assisted Survey on Antibiotic Use by Pet Owners in Dogs and Cats. Antibiotics, 13(5), 382. https://doi.org/10.3390/antibiotics13050382